Creative Planning’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
BCIM
ERSOT
JSAM
TRCT
AT
Creative Planning's PPH Position: Q1 2026 in Review
Creative Planning reduced its VanEck Pharmaceutical ETF (PPH) stake by 2.3% in Q1 2026, selling an estimated $6.92K and leaving 2,741 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #3467.
Creative Planning first reported a position in PPH in Q3 2013 and has held it in 16 quarters since. The position peaked at $1.06M in Q2 2015. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.
- Creative Planning held 2,741 shares of VanEck Pharmaceutical ETF worth $285K as of Q1 2026.
- Creative Planning sold 65 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $6.92K.
- VanEck Pharmaceutical ETF made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #3467 holding.
- Creative Planning first reported a position in VanEck Pharmaceutical ETF in Q3 2013 and has held it in 16 quarters since.
- Creative Planning's VanEck Pharmaceutical ETF position peaked at $1.06M in Q2 2015.
- 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.